Defining surrogate endpoints for clinical trials in severe Falciparum malaria.

<h4>Objective</h4> <p>To validate surrogate endpoints for mortality in intervention studies in patients with severe malaria</p> <h4>Design</h4> <p>Retrospective evaluation of large intervention studies in severe malaria</p> <h4>Setting, Patients...

Full description

Bibliographic Details
Main Authors:	Jeeyapant, A, Kingston, H, Plewes, K, Maude, R, Hanson, J, Herdman, M, Leopold, S, Ngernseng, T, Charunwatthana, P, Phu, N, Ghose, A, Hasan, M, Fanello, C, Faiz, M, Hien, T, Day, N, White, N, Dondorp, A
Format:	Journal article
Language:	English
Published:	Public Library of Science 2017

Defining surrogate endpoints for clinical trials in severe Falciparum malaria.

Similar Items